Costimulatory domain Sample Clauses

Costimulatory domain. Second-generation CARs can differ in their choice of costimulatory domain, which affects the efficacy, phenotype and metabolic properties of the resulting CAR T-cells122. In CARs the most frequently used costimulatory domains derive from the CD28 family (CD28 and ICOS) or the TNFR family (4-1BB, CD27, OX40). In their endogenous contexts CD28 family and TNFR family molecules function with notable differences, these distinctions are translated in CAR T-cells comprising of the different costimulatory domains. Second-generation CARs used in the clinic that utilize either a CD28 or 4-1BB costimulatory module and both have shown impressive outcomes123–125. Preclinical evaluations of CD28 costimulation suggest it is fundamental for early activation of naïve T-cells and promotes the rapid development of T- cell effector functions. After initiation of signal 1, T-cells require co-stimulation (signal 2) to achieve optimal activation and prevent anergy126. Endogenous T-cell co-stimulation is usually provided by CD28 once it encounters its ligands B7.1 and B7.2. This ligation results in phosphorylation of membrane proximal YMNM motif by Src family tyrosine kinases, enabling PI3K to bind and activate AKT, which leads to initiation of signalling cascades including the mTOR127,128, GRB2-SOS129 and glycogen synthase kinase 3 pathways130. CD28 contains the proline rich motifs PRRP and PYAP which bind Lck and ITK and other SH3- containing proteins such as GRB2 and filamin A129,131. Furthermore, the YMNM and PYAP motifs are essential for immunological synapse formation132. In comparison, 4-1BB is up-regulated on T-cells 24 hours after activation to stimulate proliferation, effector function and to inhibit apoptosis133,134. 4-1BB contains binding sites for TRAF1-3, and these adaptor molecules can modulate the activation of the canonical and noncanonical nuclear factor κβ (NF-κβ) pathway as well as mitogen-activated protein kinases (MAPKs)135,136. Signalling downstream of these TRAF family members up-regulates the transcription of pro-survival proteins such as BCL-2 and BCL-XL as well as proinflammatory cytokines such as IL-2 and IFN-γ137. However, in TNFR-containing CAR T- cells pathway activation occurs immediately upon CAR ligation, which potentially leads to differing biochemical function compared to non-transduced T-cells. Studies have demonstrated that activation of 4-1BB containing CARs leads to higher levels of BCL-2 and BCL-XL when compared to CD28 CARs, in keeping wi...
AutoNDA by SimpleDocs

Related to Costimulatory domain

  • Technology Discoveries, innovations, Know-How and inventions, whether patentable or not, including computer software, recognized under U.S. law as intellectual creations to which rights of ownership accrue, including, but not limited to, patents, trade secrets, maskworks and copyrights developed under this Agreement.

  • Third Party Technology The Company makes use of third party technology to collect information required for traffic measurement, research, and analytics. Use of third party technology entails data collection. We therefore would like to inform clients the Company enables third parties to place or read cookies located on the browsers of users entering the Company’s domain. Said third parties may also use web beacons to collect information through advertising located on the Company’s web site. Please note that you may change your browser settings to refuse or disable Local Shared Objects and similar technologies; however, by doing so you may be disabling some of the functionality of Company’s services.

  • Rhytidectomy Scar revision, regardless of symptoms. • Sclerotherapy for spider veins. • Skin tag removal. • Subcutaneous injection of filling material. • Suction assisted Lipectomy. • Tattooing or tattoo removal except tattooing of the nipple/areola related to a mastectomy. • Treatment of vitiligo. • Standby services of an assistant surgeon or anesthesiologist. • Orthodontic services related to orthognathic surgery. • Cosmetic procedures when performed primarily: o to refine or reshape body structures or dental structures that are not functionally impaired; o to improve appearance or self-esteem; or o for other psychological, psychiatric or emotional reasons. • Drugs, biological products, hospital charges, pathology, radiology fees and charges for surgeons, assistant surgeons, attending physicians and any other incidental services, which are related to cosmetic surgery.

  • New Technology When new or updated technology is introduced into a workplace, it will be the responsibility of the employer to provide appropriate and, if necessary, ongoing training to the employees directly affected. Such training will include any health and safety implications or information that will enable employees to operate the equipment without discomfort and will help maintain their general well-being.

  • Third Party Materials The Application may display, include, or make available third-party content (including data, information, applications, and other products, services, and/or materials) or provide links to third-party websites or services, including through third- party advertising ("Third-Party Materials"). You acknowledge and agree that Company is not responsible for Third-Party Materials, including their accuracy, completeness, timeliness, validity, copyright compliance, legality, decency, quality, or any other aspect thereof. Company does not assume and will not have any liability or responsibility to you or any other person or entity for any Third-Party Materials. Third-Party Materials and links thereto are provided solely as a convenience to you, and you access and use them entirely at your own risk and subject to such third parties' terms and conditions.

  • Research, Science and Technology Cooperation 1. The aims of cooperation in research, science and technology, carried out in the mutual interest of the Parties and in compliance with their policies, will be: (a) to build on existing agreements already in place for cooperation on research, science and technology; (b) to encourage, where appropriate, government agencies, research institutions, universities, private companies and other research organizations in the Parties to conclude direct arrangements in support of cooperative activities, programs or projects within the framework of this Agreement, specially related to trade and commerce; and (c) to focus cooperative activities towards sectors where mutual and complementary interests exist, with special emphasis on information and communication technologies and software development to facilitate trade between the Parties. 2. The Parties will encourage and facilitate, as appropriate, the following activities including, but not limited to:

  • PROGENY Unmodified descendant from the MATERIAL, such as virus from virus, cell from cell, or organism from organism.

  • Influenza Vaccine Upon recommendation of the Medical Officer of Health, all employees shall be required, on an annual basis to be vaccinated and or to take antiviral medication for influenza. If the costs of such medication are not covered by some other sources, the Employer will pay the cost for such medication. If the employee fails to take the required medication, she may be placed on an unpaid leave of absence during any influenza outbreak in the home until such time as the employee has been cleared by the public health or the Employer to return to the work environment. The only exception to this would be employees for whom taking the medication will result in the employee being physically ill to the extent that she cannot attend work. Upon written direction from the employee’s physician of such medical condition in consultation with the Employer’s physician, (if requested), the employee will be permitted to access their sick bank, if any, during any outbreak period. If there is a dispute between the physicians, the employee will be placed on unpaid leave. If the employee gets sick as a reaction to the drug and applies for WSIB the Employer will not oppose the application. If an employee is pregnant and her physician believes the pregnancy could be in jeopardy as a result of the influenza inoculation and/or the antiviral medication she shall be eligible for sick leave in circumstances where she is not allowed to attend at work as a result of an outbreak. This clause shall be interpreted in a manner consistent with the Ontario Human Rights Code.

  • Know-How The term “

  • Background Screening VENDOR shall comply with all requirements of Sections 1012.32 and 1012.465, Florida Statutes, and all of its personnel who (1) are to be permitted access to school grounds when students are present, (2) will have direct contact with students, or (3) have access or control of school funds, will successfully complete the background screening required by the referenced statutes and meet the standards established by the statutes. This background screening will be conducted by SBBC in advance of VENDOR or its personnel providing any services under the conditions described in the previous sentence. VENDOR shall bear the cost of acquiring the background screening required by Section 1012.32, Florida Statutes, and any fee imposed by the Florida Department of Law Enforcement to maintain the fingerprints provided with respect to VENDOR and its personnel. The parties agree that the failure of VENDOR to perform any of the duties described in this section shall constitute a material breach of this Agreement entitling SBBC to terminate immediately with no further responsibilities or duties to perform under this Agreement. VENDOR agrees to indemnify and hold harmless SBBC, its officers and employees from any liability in the form of physical or mental injury, death or property damage resulting from VENDOR’s failure to comply with the requirements of this section or with Sections 1012.32 and 1012.465, Florida Statutes.

Time is Money Join Law Insider Premium to draft better contracts faster.